Intensive menstrual bleeding successfully treated with recombinant factor VIIa in glanzmann thrombasthenia

Clinical and Applied Thrombosis/Hemostasis

Volumn 17, Issue 4, 2011, Pages 320-322

  Balci, Yasemin Isik ^a   Karabulut, Aysun ^a   Kabukcu, Sibel ^b   Sari, Ismail ^b   Keskin, Ali ^b  

^a DENIZLI STATE HOSPITAL   (Turkey)

^b PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

deep venous thrombosis; endocrinology; venous thromboembolism

Indexed keywords

DROSPIRENONE PLUS ETHINYLESTRADIOL; GOSERELIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; UNCLASSIFIED DRUG; ZOLODEX;

ADULT; APHERESIS; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FEMALE; GLANZMANN DISEASE; HUMAN; MENORRHAGIA; ORAL CONTRACEPTION; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM; TREATMENT RESPONSE;

FACTOR VIIA; FEMALE; HUMANS; MENORRHAGIA; MENSTRUATION; RECOMBINANT PROTEINS; THROMBASTHENIA; YOUNG ADULT;

EID: 80052725718     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029610364518     Document Type: Article

References (15)

1. Salles II, Feys HB, Iserbyt BF, De Meyer SF, Vanhoorelbeke K., Deckmyn H. Inherited traits affecting platelet function. Blood Rev. 2008 ; 22 (3). 155-172.
2. Nurden AT Glanzmann thrombasthenia. Orphanet J Rare Dis. 2006 ; 1: 10.
3. Poon MC, D'Oiron R., Von Depka M., et al, for the International Data Collection on Recombinant Factor VIIa and Congenital Platelet Disorders Study Group. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. J Thromb Haemost. 2004 ; 2 (7). 1096-1103.
4. Poon MC Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia. Vasc Health Risk Manag. 2007 ; 3 (5). 655-664.
5. Almeida AM, Khair K., Hann I., Liesner R. The use of recombinant factor VIIa in children with inherited platelet function disorders. Br J Haematol. 2003 ; 121 (3). 477-481. (Pubitemid 36628341)
6. Franchini M., Lippi G., Franchi M. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG. 2007 ; 114 (1). 8-15. (Pubitemid 44923926)
7. Moscardó F., Pérez F., de la Rubia J., et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol. 2001 ; 114 (1). 174-176. (Pubitemid 32702652)
8. Ahonen J., Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Br J Anaesth. 2005 ; 94 (5). 592-595. (Pubitemid 40613803)
9. Sajdak S., Moszynski R., Opala T. Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII. Eur J Gynaecol Oncol. 2002 ; 23 (4). 325-326. (Pubitemid 34948050)
10. Erikci AA, Ozturk A., Sayan O. Recombinant activated factor VII for severe uterine bleeding after chemotherapy in a woman with acute myeloid leukemia. Blood Coagul Fibrinolysis. 2006 ; 17 (4). 323-324.
11. Coppola A., Tufano A., Cimino E., et al. Recombinant factor VIIa in a patient with Glanzmann's thrombasthenia undergoing gynecological surgery: open issues in light of successful treatment. Thromb Haemost. 2004 ; 92 (6). 1450-1452. (Pubitemid 39642560)
12. Monte S., Lyons G. Peripartum management of a patient with Glanzmann's thrombasthenia using thrombelastograph. Br J Anaesth. 2002 ; 88 (5). 734-738. (Pubitemid 34498611)
13. Kale A., Bayhan G., Yalinkaya A., Yayla M. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery. J Perinat Med. 2004 ; 32 (5). 456-458. (Pubitemid 39304419)
14. Kaleelrahman M., Minford A., Parapia LA Use of recombinant factor VIIa in inherited platelet disorders. Br J Haematol. 2004 ; 125 (1). 95-96. (Pubitemid 38453288)
15. Erduran E., Aksoy A., Zaman D. The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy. Blood Coagul Fibrinolysis. 2009 ; 20 (3). 215-217.